General Information of Drug (ID: DM9KLQC)

Drug Name
MB-03966 Drug Info
Synonyms AK inhibitors, Gensia; AK inhibitors, SICOR; Adenosine kinase inhibitors, Metabasis; Adenosine kinase inhibitors, SICOR; GP-3966; GP-4364; MB-03691; MB-4587; Tubercidin derivatives, Metabasis
Indication
Disease Entry ICD 11 Status REF
Epileptic seizures 8A61-8A6Z Investigative [1]
Cross-matching ID
TTD Drug ID
DM9KLQC

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug(s) Targeting Adenosine kinase (ADK)
Drug Name Drug ID Indication ICD 11 Highest Status REF
GP-3269 DM035LO Convulsion 8A68.Z Phase 1 [2]
ABT-702 DMYJMV9 Pain MG30-MG3Z Terminated [3]
GP-683 DMPODL9 Pain MG30-MG3Z Terminated [4]
A-134974 DMRWDX5 Epilepsy 8A60-8A68 Terminated [5]
GP515 DMRUIX3 Discovery agent N.A. Investigative [6]
5'-iodotubercidin DML5ZEJ Discovery agent N.A. Investigative [7]
5-iodo,5'-deoxytubercidin DMVT2LW Discovery agent N.A. Investigative [8]
6-Benzylthioinosine DMNXGZP Discovery agent N.A. Investigative [9]
Iodotubercidin DMQMH6S Discovery agent N.A. Investigative [10]
⏷ Show the Full List of 9 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Adenosine kinase (ADK) TTL732K ADK_HUMAN Inhibitor [1]

References

1 Engineered Adenosine-Releasing Cells for Epilepsy Therapy: Human Mesenchymal Stem Cells and Human Embryonic Stem Cells. Neurotherapeutics. 2009 April; 6(2): 278-283.
2 Adenosine kinase inhibitors. 6. Synthesis, water solubility, and antinociceptive activity of 5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines substituted at C4 with glycinamides andrelated compounds. J Med Chem. 2005 Dec 1;48(24):7808-20.
3 ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy. Life Sci. 2013 Jul 30;93(2-3):78-88.
4 The effect of GP683, an adenosine kinase inhibitor, on the desflurane anesthetic requirement in dogs. Anesth Analg. 1997 Sep;85(3):675-80.
5 Effects of A-134974, a novel adenosine kinase inhibitor, on carrageenan-induced inflammatory hyperalgesia and locomotor activity in rats: evaluation of the sites of action. J Pharmacol Exp Ther. 2001Feb;296(2):501-9.
6 Adenosine kinase inhibitor GP515 improves experimental colitis in mice. J Pharmacol Exp Ther. 2001 Jan;296(1):99-105.
7 Inhibition of adenosine kinase attenuates interleukin-1- and lipopolysaccharide-induced alterations in articular cartilage metabolism. Osteoarthritis Cartilage. 2005 Mar;13(3):250-7.
8 Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes. J Med Chem. 2006 Nov 16;49(23):6726-31.
9 Structure-activity relationships of carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase. Bioorg Med Chem. 2010 May 15;18(10):3403-12.
10 Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012 Jan;40(Database issue):D1128-36.